리가켐바이오 Stock: price and insider trades · South Korea
No insider purchase over the last 90 days. The latest, by 김용주, was filed 04 Aug 2026.
리가켐바이오: what insiders have been doing
리가켐바이오 belongs to the Health Care sector. Filings by its managers are published through DART (FSS). 5 insiders have disclosed 5 filings since 2 November 2025.
Open-market activity splits into 2 purchases and 2 sales; 2 insiders sit on the buying side and 2 insiders on the selling side. The totals do not cover 4 filings with an undisclosed amount. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Those buying include 1 chief executive.
The most recent open-market purchase was published on 4 August 2026, 98 days ago.
For context, the typical company on the same exchange (median of 2,655 companies) published 7 filings over the same period, against 5 filings here. Since 2021, the database holds 21 purchases and 4 sales by insiders of the company.
In the same sector, recent insider purchases at Dynavox Group AB and UCB also feature in our signals. This summary is built from DART (FSS) disclosures alone and does not predict where the share price will go.
Who traded when
BuySaleTransparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- Other0DART
- 17,700 sharesShareKRXDART:20260804000151Canonical exit: 2 Nov 2026 (T+90)
- Other0DART
- Other0DART
- Other0DART
- 1,029,653 sharesShareKRXDART:20260724000649Canonical exit: 22 Oct 2026 (T+90)
- Other0DART
- 22,490 sharesKRXDART:20260401004204
- 1,490 sharesShareKRXDART:20260401004219
- ●Executives0DART
- 367,347 sharesKRXDART:20251001000571Canonical exit: 22 Dec 2025 (T+90)
- 1,838,791 sharesKRXDART:20250702000109Canonical exit: 29 Jul 2025 (T+90)
- 375,601 sharesKRXDART:20250106000259
- 38,169 sharesKRXDART:20241007000080Canonical exit: 18 Nov 2024 (T+90)
- 940 sharesKRXDART:20240701000453Canonical exit: 25 Sept 2024 (T+90)
- ShareKRXDART:20240701000446Canonical exit: 29 Sept 2024 (T+90)
- ●Executives0DART
- 2,626,428 sharesKRXDART:20240117000185Canonical exit: 14 Apr 2024 (T+90)
- 387,673 sharesKRXDART:20240108000602
- 940 sharesKRXDART:20231201000226Canonical exit: 12 Feb 2024 (T+90)
- 940 sharesKRXDART:20230818000239Canonical exit: 14 Nov 2023 (T+90)
- 940 sharesKRXDART:20230502000859Canonical exit: 13 Jul 2023 (T+90)
- 940 sharesKRXDART:20230405002933Canonical exit: 4 Jul 2023 (T+90)
- 940 sharesKRXDART:20221212000211Canonical exit: 12 Mar 2023 (T+90)
- 940 sharesKRXDART:20220714000463Canonical exit: 12 Oct 2022 (T+90)
25 of 35 declarations
About 리가켐바이오
Riga Chem Bio is a company in the health and pharmaceutical sector listed on the XKRX market. It specializes in the development of innovative biopharmaceutical solutions.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
